Zinger Key Points
- Carl Icahn boosted Illumina stake by 450%, signaling strong conviction in the biotech turnaround story.
- Icahn nearly doubled JetBlue holdings, now his 7th-largest position, betting big on airline recovery.
- Get the Strategy to Trade Pre-Fed Setups and Post-Fed Swings—Live With Chris Capre on Wednesday, June 11.
Carl Icahn is making bold moves from the lab to the tarmac.
According to his latest 13F filing for the quarter ended March 31, the billionaire activist investor significantly boosted his holdings in Illumina Inc. ILMN and JetBlue Airways Corp. JBLU – a striking bet on both biotech and airlines.
Read Also: Carl Icahn Loads Up CVR Energy Stock, Drops $27 Million On Bullish April Binge
Three Of Icahn’s Top Holdings Are Healthcare Stocks
Icahn increased his stake in Illumina by 450%, adding 180,000 shares to bring his total holding to 220,000 shares. That holding now represents 0.25% of his $7 billion portfolio, up from just 0.07% previously.
The genomics giant ranks 13th in Icahn's portfolio and was one of his top percentage gainers this quarter. The move signals renewed conviction in the embattled DNA sequencing company, which has been under pressure amid boardroom battles and regulatory scrutiny.
Icahn's top three healthcare holdings now include Bausch Health Companies Inc BHC, Bausch + Lomb Corp BLCO and Illumina – a diverse mix that spans pharma, optics, and biotech.
But that wasn't the only high-flyer in Icahn's crosshairs.
JetBlue Boost – Turnaround Potential?
He nearly doubled down on JetBlue, boosting his stake by 89.66% with a purchase of nearly 15.9 million shares.
Icahn now owns 33.6 million shares of the airline, worth over $162 million, making it the 7th largest position in his portfolio. That's up from 1.88% of the portfolio to 2.33%. Notably, Icahn first took a position in JetBlue in the first quarter of 2024, and the ramp-up suggests he sees serious turnaround potential.
While JetBlue and Illumina were among the top buys this quarter, Icahn trimmed exposure elsewhere, most notably Southwest Gas Holdings Inc SWX, which saw a 1.96% drop in portfolio allocation.
With bets spanning DNA sequencing and discount air travel, Icahn’s latest moves show he's not afraid to invest where turbulence—literal or figurative—is part of the ride.
Read Next:
Image created using artificial intelligence via Midjourney.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.